Bluebird Financial Statements From 2010 to 2024

BLUE Stock  USD 1.37  0.17  14.17%   
Bluebird Bio financial statements provide useful quarterly and yearly information to potential Bluebird Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bluebird Bio financial statements helps investors assess Bluebird Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bluebird Bio's valuation are summarized below:
Gross Profit
-247.2 M
Market Capitalization
231.3 M
Enterprise Value Revenue
16.6024
Revenue
21.7 M
Earnings Share
(0.63)
There are over one hundred nineteen available fundamental signals for Bluebird Bio, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Bluebird Bio's prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road.
Check Bluebird Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluebird main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.2 M, Selling General Administrative of 125.4 M or Total Revenue of 40.7 M, as well as many exotic indicators such as Price To Sales Ratio of 243, Dividend Yield of 0.0 or Operating Cycle of 986. Bluebird financial statements analysis is a perfect complement when working with Bluebird Bio Valuation or Volatility modules.
  
This module can also supplement Bluebird Bio's financial leverage analysis and stock options assessment as well as various Bluebird Bio Technical models . Check out the analysis of Bluebird Bio Correlation against competitors.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.

Bluebird Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.1 B638.1 M903.6 M
Slightly volatile
Other Current Liabilities55.2 M58.1 M47.7 M
Slightly volatile
Total Current Liabilities105.5 M147.5 M93.8 M
Slightly volatile
Other Liabilities101.6 K107 K23.5 M
Very volatile
Property Plant And Equipment Net351.8 M335.1 M165.2 M
Slightly volatile
Current Deferred Revenue1.3 M1.4 M10.4 M
Very volatile
Accounts Payable16.3 M28.9 M15 M
Slightly volatile
Cash123.5 M130 M229.9 M
Pretty Stable
Non Current Assets Total350.9 M408.7 M305.9 M
Slightly volatile
Other Assets33.2 M59.9 M30.4 M
Slightly volatile
Cash And Short Term Investments198.6 M209 M602.1 M
Pretty Stable
Common Stock Total Equity431.4 K817.6 K418.4 K
Slightly volatile
Common Stock Shares Outstanding47.4 M90.4 M45.2 M
Slightly volatile
Liabilities And Stockholders Equity1.1 B638.1 M903.6 M
Slightly volatile
Non Current Liabilities Total154.1 M264.9 M145.6 M
Slightly volatile
Other Current Assets9.1 M9.6 M16.2 M
Slightly volatile
Other Stockholder Equity5.1 B4.8 B2.3 B
Slightly volatile
Total Liabilities259.6 M412.3 M239.4 M
Slightly volatile
Property Plant And Equipment Gross378.3 M360.3 M171.5 M
Slightly volatile
Total Current Assets217.9 M229.4 M563.5 M
Pretty Stable
Short Term Debt61.8 M58.8 M22.6 M
Slightly volatile
Common StockM954.5 K473.5 K
Slightly volatile
Property Plant Equipment351.8 M335.1 M140.6 M
Slightly volatile
Net Tangible Assets203 M213.7 M647.9 M
Pretty Stable
Net Receivables11 M12.4 M8.3 M
Slightly volatile
Capital Surpluse2.6 B4.7 B2.2 B
Slightly volatile
Deferred Long Term Liabilities38 M28.2 M31.6 M
Slightly volatile
Non Current Liabilities Other100.5 K105.8 K35.4 M
Pretty Stable
Long Term Investments1.2 M1.3 M120.4 M
Very volatile
Short and Long Term Debt Total171.5 M323.6 M136.8 M
Slightly volatile
Long Term Debt Total134.8 M176.3 M114.9 M
Slightly volatile
Short and Long Term Debt123.9 M179.2 M115.3 M
Slightly volatile
Capital Lease Obligations186.3 M323.6 M161.1 M
Slightly volatile
Net Invested Capital167.9 M176.7 M1.2 B
Slightly volatile
Net Working Capital60.9 M64.1 M894 M
Slightly volatile
Capital Stock727.5 K954.5 K624.3 K
Slightly volatile

Bluebird Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative125.4 M149.1 M107.5 M
Slightly volatile
Total Revenue40.7 M21.7 M34.9 M
Slightly volatile
Other Operating Expenses385.4 M328.6 M329 M
Slightly volatile
Research Development261.8 M179.8 M224.4 M
Slightly volatile
Cost Of Revenue35.5 M23.9 M41.9 M
Pretty Stable
Total Operating Expenses150 M157.9 M297.9 M
Slightly volatile
Interest Income7.5 M8.3 M6.1 M
Slightly volatile
Reconciled Depreciation4.2 M4.4 M13 M
Slightly volatile
Extraordinary Items84.8 M95.4 M103.9 M
Slightly volatile
Non Recurring20.6 M23.2 M25.3 M
Slightly volatile

Bluebird Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation19.7 M20.7 M52.4 M
Slightly volatile
Begin Period Cash Flow106 M111.6 M231.8 M
Slightly volatile
Depreciation4.2 M4.4 M8.2 M
Slightly volatile
Capital Expenditures8.5 MM21.3 M
Slightly volatile
End Period Cash Flow305 M218.4 M262.3 M
Slightly volatile
Sale Purchase Of Stock87.8 M92.4 M161.3 M
Very volatile
Issuance Of Capital Stock123.4 M129.9 M520 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio243174235
Slightly volatile
Days Of Payables Outstanding993K2.8 K
Slightly volatile
Ebt Per Ebit1.091.071.0013
Very volatile
Payables Turnover0.320.360.26
Slightly volatile
Long Term Debt To Capitalization0.510.490.1638
Slightly volatile
Cash Per Share1.962.0711.9389
Very volatile
Quick Ratio1.631.717.6371
Slightly volatile
Net Income Per E B T0.780.90.9137
Slightly volatile
Cash Ratio0.961.014.7741
Slightly volatile
Days Of Sales OutstandingK985316
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.860.931.0418
Pretty Stable
Current Ratio1.71.798.0173
Slightly volatile
Fixed Asset Turnover0.01350.01420.5127
Slightly volatile
Debt Ratio0.480.460.1576
Slightly volatile
Price Sales Ratio243174235
Slightly volatile
Receivables Turnover0.360.387.2812
Slightly volatile
Asset Turnover0.00550.00580.03
Pretty Stable

Bluebird Fundamental Market Drivers

Cash And Short Term Investments181.7 M

Bluebird Upcoming Events

3rd of April 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Bluebird Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bluebird Bio income statement, its balance sheet, and the statement of cash flows. Bluebird Bio investors use historical funamental indicators, such as Bluebird Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bluebird Bio investors may use each financial statement separately, they are all related. The changes in Bluebird Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bluebird Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bluebird Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bluebird Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Current Deferred Revenue1.4 M1.3 M
Total Revenue21.7 M40.7 M
Cost Of Revenue23.9 M35.5 M
Ebit Per Revenue(91.79)(87.20)

Pair Trading with Bluebird Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bluebird Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bluebird Stock

  0.62MDGL Madrigal Pharmaceuticals Financial Report 14th of May 2024 PairCorr

Moving against Bluebird Stock

  0.68VBIV VBI Vaccines Financial Report 20th of May 2024 PairCorr
  0.51TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Bluebird Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bluebird Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bluebird Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bluebird Bio to buy it.
The correlation of Bluebird Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bluebird Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bluebird Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bluebird Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Bluebird Bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:
Check out the analysis of Bluebird Bio Correlation against competitors.
For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Bluebird Stock analysis

When running Bluebird Bio's price analysis, check to measure Bluebird Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluebird Bio is operating at the current time. Most of Bluebird Bio's value examination focuses on studying past and present price action to predict the probability of Bluebird Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluebird Bio's price. Additionally, you may evaluate how the addition of Bluebird Bio to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Is Bluebird Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.63)
Revenue Per Share
0.214
Quarterly Revenue Growth
173.535
Return On Assets
(0.15)
Return On Equity
(0.48)
The market value of Bluebird Bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.